학술논문
New combination therapies with subcutaneous epcoritamab in first-line therapy and in relapsed non-Hodgkin lymphoma. A phase 1b/2 multicenter, open-label study to assess safety, tolerability, and efficacy
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
22965262